123 related articles for article (PubMed ID: 16857194)
1. Circadian clock genes cause activation of the human PAI-1 gene promoter with 4G/5G allelic preference.
Chong NW; Codd V; Chan D; Samani NJ
FEBS Lett; 2006 Aug; 580(18):4469-72. PubMed ID: 16857194
[TBL] [Abstract][Full Text] [Related]
2. Binding of upstream stimulatory factor 1 to the E-box regulates the 4G/5G polymorphism-dependent plasminogen activator inhibitor 1 expression in mast cells.
Ma Z; Jhun B; Jung SY; Oh CK
J Allergy Clin Immunol; 2008 Apr; 121(4):1006-1012.e2. PubMed ID: 18234320
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator inhibitor-1 and asthma: role in the pathogenesis and molecular regulation.
Ma Z; Paek D; Oh CK
Clin Exp Allergy; 2009 Aug; 39(8):1136-44. PubMed ID: 19438580
[TBL] [Abstract][Full Text] [Related]
4. PERIOD2 is a circadian negative regulator of PAI-1 gene expression in mice.
Oishi K; Miyazaki K; Uchida D; Ohkura N; Wakabayashi M; Doi R; Matsuda J; Ishida N
J Mol Cell Cardiol; 2009 Apr; 46(4):545-52. PubMed ID: 19168071
[TBL] [Abstract][Full Text] [Related]
5. A direct repeat of E-box-like elements is required for cell-autonomous circadian rhythm of clock genes.
Nakahata Y; Yoshida M; Takano A; Soma H; Yamamoto T; Yasuda A; Nakatsu T; Takumi T
BMC Mol Biol; 2008 Jan; 9():1. PubMed ID: 18177499
[TBL] [Abstract][Full Text] [Related]
6. Allele-specific transcription of the PAI-1 gene in human astrocytes.
Hultman K; Tjarnlund-Wolf A; Odeberg J; Eriksson P; Jern C
Thromb Haemost; 2010 Nov; 104(5):998-1008. PubMed ID: 20806116
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen activator inhibitor 1 expression in platelets is not influenced by the 4G/5G promoter polymorphism.
Brogren H; Wallmark K; Jern S; Karlsson L
Thromb Res; 2008; 121(6):793-7. PubMed ID: 17884148
[TBL] [Abstract][Full Text] [Related]
8. Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in Turkish patients with generalized aggressive periodontitis.
Emingil G; Berdeli A; Gürkan A; Han Saygan B; Köse T; Atilla G
J Clin Periodontol; 2007 Apr; 34(4):278-84. PubMed ID: 17257155
[TBL] [Abstract][Full Text] [Related]
9. Distribution of PAI-1 promoter 4G/5G polymorphism in healthy Chinese and functional characterization using a luciferase reporter vector.
Ding Z; Pan JQ
Ann Hematol; 2005 Mar; 84(3):183-7. PubMed ID: 15309528
[TBL] [Abstract][Full Text] [Related]
10. Involvement of circadian clock gene Clock in diabetes-induced circadian augmentation of plasminogen activator inhibitor-1 (PAI-1) expression in the mouse heart.
Oishi K; Ohkura N; Amagai N; Ishida N
FEBS Lett; 2005 Jul; 579(17):3555-9. PubMed ID: 15950223
[TBL] [Abstract][Full Text] [Related]
11. Myocardial infarction occurs with a similar 24 h pattern in the 4G/5G versions of plasminogen activator inhibitor-1.
Bergheanu SC; Pons D; Jukema JW; van der Hoeven BL; Liem SS; Vandenbroucke JP; Rosendaal FR; le Cessie S; Schalij MJ; van der Bom JG
Chronobiol Int; 2009 May; 26(4):637-52. PubMed ID: 19444746
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.
Jorgenson E; Deitcher SR; Cicek M; Liu X; Plummer S; Casey G; Witte JS
Prostate; 2007 Feb; 67(2):172-7. PubMed ID: 17044080
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the PAI-1 promoter by circadian clock components: differential activation by BMAL1 and BMAL2.
Schoenhard JA; Smith LH; Painter CA; Eren M; Johnson CH; Vaughan DE
J Mol Cell Cardiol; 2003 May; 35(5):473-81. PubMed ID: 12738229
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.
Ramón LA; Gilabert-Estellés J; Cosín R; Gilabert J; España F; Castelló R; Chirivella M; Romeu A; Estellés A
Thromb Res; 2008; 122(6):854-60. PubMed ID: 18423526
[TBL] [Abstract][Full Text] [Related]
15. Effect of 4G/5G PAI-1 polymorphism on the response of PAI-1 activity to vitamin E supplementation in Type 2 diabetic patients.
Testa R; Bonfigli AR; Sirolla C; Boemi M; Manfrini S; Mari D; Testa I; Sacchi E; Franceschi C
Diabetes Nutr Metab; 2004 Aug; 17(4):217-21. PubMed ID: 15575342
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the ovine MT1 melatonin receptor promoter: interaction between multiple pituitary transcription factors at different phases of development.
Johnston JD; Schuster C; Barrett P; Hazlerigg DG
Mol Cell Endocrinol; 2007 Mar; 268(1-2):59-66. PubMed ID: 17337323
[TBL] [Abstract][Full Text] [Related]
17. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.
Funk M; Endler G; Exner M; Marculescu R; Endler L; Abrahamian H; Mauler H; Grimm A; Raith M; Mannhalter C; Prager R; Irsigler K; Wagner OF
Wien Klin Wochenschr; 2005 Oct; 117(19-20):707-10. PubMed ID: 16416371
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms at FCER1B and PAI-1 and asthma susceptibility.
Hizawa N; Maeda Y; Konno S; Fukui Y; Takahashi D; Nishimura M
Clin Exp Allergy; 2006 Jul; 36(7):872-6. PubMed ID: 16839401
[TBL] [Abstract][Full Text] [Related]
19. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
Pérez-Martínez P; Adarraga-Cansino MD; Fernández de la Puebla RA; Blanco-Molina A; Delgado-Lista J; Marín C; Ordovás JM; López-Miranda J; Pérez-Jiménez F
Br J Nutr; 2008 Apr; 99(4):699-702. PubMed ID: 17903340
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator inhibitor-1 and the circadian clock in metabolic disorders.
Oishi K
Clin Exp Hypertens; 2009 May; 31(3):208-19. PubMed ID: 19387897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
